Mednax Inc $ 22.95 -0.77 (-3.25%)
On watch
Volume:
1,217,278
Avg Vol (1m):
939,319
Market Cap $:
1.93 Bil
Enterprise Value $:
4.00 Bil
P/E (TTM):
9.98
P/B:
0.70
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
| DCF (FCF Based) | ||
| DCF (Earnings Based) | ||
|
Price: $22.95 | ||
Manual of Stocks™ Web
Financial Strength | 4/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.05 | ||
| Equity-to-Asset | 0.48 | ||
| Debt-to-Equity | 0.8 | ||
| Debt-to-EBITDA | 4.39 | ||
| Interest Coverage | 3.41 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 1.8 | ||
| Beneish M-Score | -2.95 | ||
| WACC vs ROIC | |||
Profitability | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 10.47 | ||
| Net Margin % | -3.53 | ||
| ROE % | -4.24 | ||
| ROA % | -2.16 | ||
| ROC (Joel Greenblatt) % | 87.74 | ||
| 3-Year Revenue Growth Rate | 10.4 | ||
| 3-Year EBITDA Growth Rate | -2.4 | ||
| 3-Year EPS without NRI Growth Rate | -6.5 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Forward PE Ratio | 6.35 | ||
| PE Ratio without NRI | 9.98 | ||
| PB Ratio | 0.7 | ||
| PS Ratio | 0.57 | ||
| Price-to-Free-Cash-Flow | 7.11 | ||
| Price-to-Operating-Cash-Flow | 6.1 | ||
| EV-to-EBIT | 10.42 | ||
| EV-to-EBITDA | 8.08 | ||
| EV-to-Revenue | 1.13 | ||
| PEG Ratio | 2.13 | ||
| Shiller PE Ratio | 8.61 | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 2.23 | ||
| Days Sales Outstanding | 51.86 | ||
| Days Payable | 4.5 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.2 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 0.29 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 0.78 | ||
| Price-to-Median-PS-Value | 0.27 | ||
| Earnings Yield (Greenblatt) % | 9.6 | ||
| Forward Rate of Return (Yacktman) % | 18.39 |